Preview

Непрерывное мониторирование гликемии в клинической практике и новые методы анализа его результатов

https://doi.org/10.14341/probl201359441-49

Полный текст:

Аннотация

Рассматриваются современное состояние метода непрерывного мониторирования гликемии, показания к его применению, информационно-терапевтические возможности и технические аспекты. Подчеркивается отсутствие улучшения контроля гликемии при рутинном применении непрерывного мониторирования гликемии и обсуждаются его потенциальные преимущества при ряде клинических ситуаций у больных сахарным диабетом. Особое внимание уделяется методам математического анализа результатов непрерывного мониторирования гликемии.

Список литературы

1. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой. Изд. 5-е. М 2011.

2. American Diabetes Association. Standards of medical care in diabetes. Diabet Care 2011; 34: Suppl 1: S11-S61.

3. Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabet Care 2005; 28: 1245-1249.

4. Akalin S., Berntorp K., Ceriello A., Das A.K., Kilpatrick E.S., Koblik T., Munichoodappa C.S., Pan C.Y., Rosenthall W., Shestakova M., Wolnik B., Woo V., Yang W.Y., Yilmaz M.T. Global Task Force on Glycaemic Control. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control Int J Clin Pract 2009; 63: 10: 1421-1425.

5. Balkau B., Hu G., Qiao Q., Tuomilehto J., Borch-Johnsen K., Pyörälä K., DECODE Study Group; European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 2004; 47: 2118-2128.

6. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005; 54: 1-7.

7. Kilpatrick E.S., Rigby A.S., Goode K., Atkin S.L. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 2007; 50: 2553-2561.

8. Аметов А.С., Карпова Е.В., Мельник А.В. Значение непрерывного мониторинга гликемии у пациентов с сахарным диабетом. РМЖ 2008; 28: 1845.

9. Анциферов М.Б., Котешкова О.М., Орлова Е.В. Современные технические средства в лечении сахарного диабета (дозаторы инсулина, системы НМГ). Фарматека 2006; 17: 2-5.

10. Boland E., Monsod T., Delucia M., Brandt C.A., Fernando S., Tamborlane W.V. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabet Care 2001; 24: 1858-1862.

11. Brownlee M., Hirsch I.B. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications JAMA 2006; 295: 1707-1708.

12. Lachin J.M., Genuth S., Nathan D.M., Zinman B., Rutledge B.N., DCCT/EDIC Research Group. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial revisited. Diabet 2008; 57: 995-1001.

13. Barr E., Zimmet P., Welborn T., Jolley D., Magliano D.J., Dunstan D.W., Cameron A.J., Dwyer T., Taylor H.R., Tonkin A.M., Wong T.Y., McNeil J., Shaw J.E. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116: 2: 151-157.

14. Raz I., Wilson P.W., Strojek K., Kowalska I., Bozikov V., Gitt A.K., Jermendy G., Campaigne B.N., Kerr L., Milicevic Z., Jacober S.J. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabet Care 2009; 32: 3: 381-386.

15. Siegelaar S.E., Kerr L., Jacober S.J., Devries J.H. A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study. Diabet Care 2011; 34: 4: 855-857.

16. Holman R.R., Haffner S.M., McMurray J.J., Bethel M.A., Holzhauer B., Hua T.A., Belenkov Y., Boolell M., Buse J.B., Buckley B.M., Chacra A.R., Chiang F.T., Charbonnel B., Chow C.C., Davies M.J., Deedwania P., Diem P., Einhorn D., Fonseca V., Fulcher G.R., Gaciong Z., Gaztambide S., Giles T., Horton E., Ilkova H., Jenssen T., Kahn S.E., Krum H., Laakso M., Leiter L.A., Levitt N.S., Mareev V., Martinez F., Masson C., Mazzone T., Meaney E., Nesto R., Pan C., Prager R., Raptis S.A., Rutten G.E., Sandstroem H., Schaper F., Scheen A., Schmitz O., Sinay I., Soska V., Stender S., Tamás G., Tognoni G., Tuomilehto J., Villamil A.S., Vozár J., Califf R.M., NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362: 16: 1463-1476.

17. Clarke W., Kovatchev B. Continuous glucose sensors: continuing questions about clinical accuracy. J Diabet Sci Technol 2007; 1: 669-675.

18. Kovatchev B., Gonder-Frederick L., Cox D., Clarke W. Evaluating the accuracy of continuous glucose monitoring sensors. Diabet Care 2004; 27: 1922-1928.

19. Keenan D., Mastrototaro J., Voskanyan G., Steil G. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabet Sci Technol 2009; 3: 5: 1207-1214.

20. Clarke W., Anderson S., Breton M., Patek S., Kashmer L., Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabet Sci Technol 2009; 3: 5: 1031-1038.

21. D'Archangelo M.J. Unlocking the potential of continuous glucose monitoring: a new guideline supports the development of continuous glucose monitoring devices. J Diabet Sci Technol 2009; 3: 2: 363-365.

22. Gross T.M., Mastrototaro J. Efficacy and reliability of the continuous glucose monitoring system. Diabet Technol Ther 2000; 2: Suppl 1: 19-26.

23. Breton M., Kovatchev B., Dalla Man C., Cobelli C. In Silico Preclinical Trials: a proof of concept in closed-loop control of type 1 diabetes. Diabet Sci Technol 2008; 2: 5: 853-862.

24. Garg S., Zisser H., Schwartz S., Bailey T., Kaplan R., Ellis S., Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabet Care 2006; 29: 44-50.

25. Kovatchev B., Anderson S., Heinemann L., Clarke W. Comparison of the numerical and clinical accuracy of four continuous glucose monitor. Diabet Care 2008; 31: 1160-1164.

26. Kovatchev B., Breton M., Clarke W.L. Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes. Methods Enzymol 2009; 454: 69-86.

27. Clarke W., Kovatchev B. Statistical tools to analyze continuous glucose monitor data. Diabet Technol Ther 2009; 11: Suppl 1: 45-54.

28. Evert A., Trence D., Catton S., Huynh P. Continuous glucose monitoring technology for personal use: an educational program that educates and supports the patient. Diabet Educ 2009; 35: 4: 565-567, 571-573, 577-580.

29. Петряйкина Е.Е., Пронина Е.А., Рыбкина И.Г., Михайлова Т.Д., Манджиева Э.Т., Духарева О.В. Оптимизация контроля гликемии при нарушении углеводного обмена у детей. Педиатрия 2007; 3: 58-65.

30. Chetty V., Almulla A., Odueyungbo A., Thabane L. The effect of continuous subcutaneous glucose monitoring (CGM) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. Diabet Res Clin Pract 2008; 81: 1: 79-87.

31. Tanenberg R., Newton C., Drake A. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. Endocrinol Pract 2010; 16: 2: 244-248.

32. McGowan K., Thomas W., Moran A. Spurious reporting of noctural hypoglycemia by CGM in patients with tightly controlled Type 1 diabetes. Diabet Care 2002; 25: 1499-1503.

33. Ryan E., Germsheid J. Use of continuous glucose monitoring system in the management of severe hypoglycemia. Diabet Technol Ther 2009; 11: 10: 635-639.

34. Bevier W., Zisser H., Jovanovic L., Finan D., Palerm C., Seborg D., Doyle F. Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone. J Diabet Sci Technol 2008; 2: 4: 578-583.

35. Daenen S., Sola-Gazagnes A., M'Bemba J., Dorange-Breillard C., Defer F., Elgrably F., Larger E., Slama G. Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients. Diabet Metabol 2010; 36: 2: 165-169.

36. Wilson D., Block J. Real-time continuous glucose monitor use and patient selection: what have we learned and where are we going. Diabet Technol Ther 2005; 7: 788-791.

37. Logtenberg S., Kleefstra N., Snellen F., Groenier K., Slingerland R., Nierich A., Bilo H. Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabet Technol Ther 2009; 11: 1: 31-37.

38. Radermecker R., Sultan A., Piot C., Remy A., Avignon A., Renard E. Continuous glucose monitoring as a tool to identify hyperglycaemia in non-diabetic patients with acute coronary syndromes. Diabet Med 2009; 26: 2: 167-170.

39. Rodríguez L., Knight R., Heptulla R. Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation. Diabet Technol Ther 2010; 12: 5: 347-351.

40. Iafusco D., Stoppoloni F., Salvia G., Vernetti G., Passaro P., Petrovski G., Prisco F. Use of real time continuous glucose monitoring and intravenous insulin in type 1 diabetic mothers to prevent respiratory distress and hypoglycaemia in infants. BMC Pregnancy Childbirth 2008; 1: 8: 23.

41. Iglesias Platas I., Thió Lluch M., Pociello Almiñana N., Morillo Palomo A., Iriondo Sanz M., Krauel Vidal X. Continuous glucose monitoring in infants of very low birth weight. Neonatology 2009; 95: 3: 217-223.

42. Signal M., Pretty C., Chase J., Le Compte A., Shaw G. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost? J Diabet Sci Technol 2010; 4: 3: 625-635.

43. Rabiee A., Andreasik R., Abu-Hamdah R., Galiatsatos B., Khouri Z., Gibson B., Andersen D., Elahi D. Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units. J Diabet Sci Technol 2009; 3: 4: 951-959.

44. Klonoff D.C., Buckingham B., Christiansen J.S., Montori V.M., Tamborlane W.V., Vigersky R.A., Wolpert H. Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guidelines. Clin Endocrinol Metabol 2011; 96: 10: 2968-2979.

45. Schiaffini R., Brufani C., Russo B., Fintini D., Migliaccio A., Pecorelli L., Bizzarri C., Lucidi V., Cappa M. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. Eur J Endocrinol 2010; 162: 4: 705-710.

46. Fox L., Beck R., Xing D. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabet Care 2010; 33: 6: 1297-1299.

47. Bao Y., Zhou J., Zhou M., Cheng Y., Lu W., Pan X., Tang J., Lu H., Jia W. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes. Clin Exp Pharmacol Physiol 2010; 7: 5-6: 564-568.

48. Overland J., Molyneaux L., Tewari S., Fatouros R., Melville P., Foote D., Wu T., Yue D. Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system. Diabet Obes Metabol 2009; 11: 5: 460-463.

49. Simon B., Treat V., Marco C., Rosenberg D., Joseph J., Hipszer B., Li Y., Chervoneva I., Padron-Massara L., Jabbour S. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. Int J Clin Pract 2008; 62: 12: 1858-1863.

50. Древаль А.В. Лечение сахарного диабета и сопутствующих заболеваний. М: Эксмо 2010.

51. Cooke D., Hurel S., Casbard A., Steed L., Walker S., Meredith S., Nunn A., Manca A., Sculpher M., Barnard M., Kerr D., Weaver J., Ahlquist J., Newman S. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study). Diabet Med 2009; 26: 5: 540-547.

52. Newman S., Cooke D., Casbard A., Walker S., Meredith S., Nunn A., Steed L., Manca A., Sculpher M., Barnard M., Kerr D., Weaver J., Ahlquist J., Hurel S. A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technol Ass 2009; 13: 28: 1-194.

53. Langendam M., Luijf Y.M., Hooft L., Devries J.H., Mudde A.H., Scholten R.J. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012; 1: CD008101.

54. Pickup J.C., Freeman S.C., Sutton A.J. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: metaanalysis of randomised controlled trials using individual patient data. BMJ 2011; 343: d3805.

55. Kovatchev B., Straume M., Cox D., Farhy L. Risk analysis of blood glucose data: a quantitative approach to optimizing the control of insulin dependent diabetes. J Theor Med 2000; 3: 1-10.

56. Baghurst P.A. Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabet Technol Ther 2011; 13: 3: 296-302.

57. Kovatchev B., Clarke W., Breton M., Brayman K., McCall A. Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabet Technol Ther 2005; 7: 849-862.

58. Kovatchev B., Otto E., Cox D., Gonder-Frederick L., Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabet Care 2006; 29: 2433-2438.

59. Pretty C., Chase J., Le Compte A., Shaw GM., Signal M. Hypoglycemia detection in critical care using continuous glucose monitors: an in silico proof of concept analysis. J Diabet Sci Technol 2010; 4: 1: 15-24.

60. Kovatchev B., Cox D., Gonder- Frederick L., Clarke W. Symmetrization of the blood glucose measurement scale and its applications. Diabet Care 1997; 20: 1655-1658.

61. Kovatchev B., Cox D., Gonder-Frederick L., Clarke W. Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. Diabet Tech Ther 2002; 4: 295-303.

62. Kovatchev B., Cox D., Kumar A., Gonder-Frederick L., Clarke W. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabet Technol Ther 2003; 5: 817-828.


Для цитирования:


., ., . Непрерывное мониторирование гликемии в клинической практике и новые методы анализа его результатов. Проблемы Эндокринологии. 2013;59(4):41-49. https://doi.org/10.14341/probl201359441-49

For citation:


Dreval' A.V., Dreval' O.A., Starostina E.G. Continuous monitoring blood glucose level in clinical practice and new methods for its analysis. Problems of Endocrinology. 2013;59(4):41-49. (In Russ.) https://doi.org/10.14341/probl201359441-49

Просмотров: 30


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)